Sutent and Torisel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sutent (sunitinib malate) and Torisel (temsirolimus). Common drug interactions include vomiting among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Sutent and Torisel. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Sutent?

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. eHealthMe is studying from 44,554 Sutent users. Check the latest studies of Sutent.

What is Torisel?

Torisel has active ingredients of temsirolimus. eHealthMe is studying from 3,205 Torisel users. Check the latest studies of Torisel.

On Jul, 14, 2026

96 people who take Sutent and Torisel together, and have interactions are studied.

What are the common drug interactions of Sutent and Torisel, by gender? *:

female:

Vomiting
Death
Pain
Pulmonary oedema (fluid accumulation in the lungs)
Asthenia (weakness)
Disease progression
Drug ineffective
Cardiac disorder
Cardiotoxicity (damage to the heart muscle)
Erythema (redness of the skin)

male:

Fatigue (feeling of tiredness)
Pleural effusion (water on the lungs)
Myalgia (muscle pain)
Neuropathy peripheral (surface nerve damage)
Pain
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Spinal cord compression
Tongue ulceration (ulcers on tongue)
Hypoaesthesia (reduced sense of touch or sensation)
Injury

What are the common drug interactions of Sutent and Torisel, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Disease progression
Muscular weakness (muscle weakness)

40-49:

Constipation
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Decreased appetite
Depression
Disability
Drug toxicity
Dyskinesia (abnormality or impairment of voluntary movement)
Fatigue (feeling of tiredness)
Gingival ulceration (ulcer on gums)
Haematocrit decreased

50-59:

Decreased appetite
Haemorrhagic diathesis (bleeding tendency)
Hypertension (high blood pressure)
Disease progression
Interstitial lung disease
Lung disorder (lung disease)
Abdominal pain
Hyperhidrosis (abnormally increased sweating)

60+:

Disease progression
Death
Alopecia (absence of hair from areas of the body)
Blood pressure increased
Hair colour changes
Impaired healing
Infection
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Neoplasm malignant (cancer tumour)

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 22 people, 22.92%
Pain: 14 people, 14.58%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 11 people, 11.46%
Bone Density Decreased: 11 people, 11.46%

* Approximation only. Some reports may have incomplete information.

Do you take Sutent and Torisel?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously